In HNSCC, homozygous deletion or mutation of CDKN2A (encoding the p16 protein) is observed in 58% of patients, and amplification of CCND1 (encoding the Cyclin D1 protein) is observed in 31% of patients6. Here, CCND1 is linked to head and neck squamous cell carcinoma.